Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rhythm Biosciences Ltd. (AU:RHY)
ASX:RHY
RHY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.14
Previous CloseN/A
Volume786.78K
Average Volume (3M)360.55K
Market Cap
AU$26.98M
Enterprise ValueAU$14.28M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.54
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding290,096,740
10 Day Avg. Volume328,472
30 Day Avg. Volume360,549
Standard Deviation0.36
R-Squared0.10
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Rhythm Biosciences Ltd. News
PremiumCompany Announcements
FIL Limited Secures Significant Stake in Rhythm Biosciences
PremiumCompany Announcements
Rhythm Biosciences Completes Initial Integration of geneType Business
PremiumCompany Announcements
Rhythm Biosciences Expands with Strategic Genetype Acquisition
PremiumCompany Announcements
Rhythm Biosciences Announces Genetype Acquisition Update
PremiumCompany Announcements
Rhythm Biosciences Acquires geneType Business AssetsPremiumCompany Announcements
Rhythm Biosciences Issues Unquoted Employee Securities
PremiumCompany Announcements
Rhythm Biosciences Expands with Genetype AcquisitionPremiumCompany Announcements
Rhythm Biosciences Initiates Trading Halt Pending Acquisition News---
Options Prices
Currently, No data available
---
Ownership Overview
RHY FAQ
What was Rhythm Biosciences Ltd.’s price range in the past 12 months?
Rhythm Biosciences Ltd. lowest share price was AU$0.04 and its highest was AU$0.14 in the past 12 months.
What is Rhythm Biosciences Ltd.’s market cap?
Rhythm Biosciences Ltd.’s market cap is AU$26.98M.
When is Rhythm Biosciences Ltd.’s upcoming earnings report date?
Rhythm Biosciences Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 4 days.
How were Rhythm Biosciences Ltd.’s earnings last quarter?
Rhythm Biosciences Ltd. released its earnings results on Aug 29, 2024. The company reported -AU$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.012.
Is Rhythm Biosciences Ltd. overvalued?
According to Wall Street analysts Rhythm Biosciences Ltd.’s price is currently Overvalued.
Does Rhythm Biosciences Ltd. pay dividends?
Rhythm Biosciences Ltd. does not currently pay dividends.
What is Rhythm Biosciences Ltd.’s EPS estimate?
Rhythm Biosciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rhythm Biosciences Ltd. have?
Rhythm Biosciences Ltd. has 290,096,740 shares outstanding.
What happened to Rhythm Biosciences Ltd.’s price movement after its last earnings report?
Rhythm Biosciences Ltd. reported an EPS of -AU$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.286%.
Which hedge fund is a major shareholder of Rhythm Biosciences Ltd.?
Currently, no hedge funds are holding shares in AU:RHY
---
Rhythm Biosciences Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:RHY Sentiment 60%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.06%
12-Months-Change
Fundamentals
Return on Equity
-71.10%
Trailing 12-Months
Asset Growth
205.13%
Trailing 12-Months
Company Description
Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.
---
Technical Analysis
Cochlear Limited
―
CSL
―
Fisher & Paykel Healthcare Corporation Limited
―
Nanosonics Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
---